Using zymography and computer assisted image analysis, we have measure
d the levels of type IV collagenases in biopsies from normal breast, a
nd benign and malignant breast disease. The 92 kDa form was present in
three of 11 cases of normal/benign disease, three of nine grade I tum
ours, four of 12 grade II tumours, but 11 of 11 grade III tumours. Mea
n levels were higher in grade III tumours (P<0.0001). When the levels
of 72 kDa collagenase and its active 62 kDa form were considered toget
her, there was no difference between the benign and malignant cases (P
= 0.55), but the amount of active enzyme, considered as a proportion
of the 62 + 72 kDa forms, was significantly higher in malignant diseas
e (P = 0.003). There was also a trend towards a higher proportion of a
ctive enzyme with increasing tumour grade (P<0.0001). In situ hybridis
ation and immunohistochemistry studies showed that that mRNA and prote
in for the 92 kDa enzyme was primarily found in the tumour stroma. mRN
A for the 72 kDa enzyme was also found in stromal areas. This study de
monstrates a clear relationship between production of Type IV collagen
ases and malignant breast disease. Inhibitors of these enzymes may be
of value in preventing metastatic disease.